C-R Relationship between Fasting Plasma Glucose and Unfavorable Outcomes in Patients of Ischemic Stroke withoutDiabetes

J Stroke Cerebrovasc Dis. 2019 May;28(5):1400-1408. doi: 10.1016/j.jstrokecerebrovasdis.2019.02.009. Epub 2019 Mar 11.

Abstract

Background: Limited data are available on the impact of fasting plasma glucose (FPG) on outcomes in nondiabetic acute ischemic stroke patients.

Methods: The prospective, multi-center, and observational study was performed at 8 hospitals in the Liaoning Province between 2015-2016, sought to elucidate the relationship between FPG and the 6-month functional outcomes in nondiabetic acute ischemic stroke patients. The primary effect measure was the adjusted odds ratio for a shift in the direction of unfavorable outcome on the modified Rankin Scale (mRS) score at 6 months, estimated with an ordinal logistic regression, and adjusted for common prognostic factors. Finally, we employed a restricted cubic spline function of linear model to characterize concentration-response (C-R) relationships between FPG and outcomes.

Results: A total of 1260 consecutive patients were enrolled, 48.9% of patients had FPG levels >6.1mmol/L. A total of 282 (22.4%) patients achieved an unfavorable neurologic outcome. Patients achieving an unfavorable neurologic outcome had significantly higher levels of FPG than those achieving a favorable neurologic outcome (6.47mmol/L versus 7.02 mmol/L). FPG was significantly related to an unfavorable neurologic outcome in nondiabetic acute ischemic stroke patients. The C-R curve showed a nonlinear relation between FPG and 6-month mRS with the nadir at 5.9mmol/L. Moreover, the likelihood of unfavorable outcome increased by 8.5% for each 1mmol/L increase in FPG.

Conclusions: Early identification and prompt hyperglycemia management should be considered to improve the functional outcomes during the early poststroke stage.

Keywords: Ischemic stroke; diabetes; fasting plasma glucose; restricted cubic spline.

Publication types

  • Multicenter Study
  • Observational Study

MeSH terms

  • Aged
  • Aged, 80 and over
  • Biomarkers / blood
  • Blood Glucose / metabolism*
  • Brain Ischemia / blood*
  • Brain Ischemia / diagnosis
  • Brain Ischemia / physiopathology
  • Brain Ischemia / therapy*
  • China
  • Disability Evaluation
  • Fasting / blood*
  • Female
  • Humans
  • Male
  • Middle Aged
  • Prospective Studies
  • Recovery of Function
  • Risk Factors
  • Stroke / blood*
  • Stroke / diagnosis
  • Stroke / physiopathology
  • Stroke / therapy*
  • Time Factors
  • Treatment Outcome

Substances

  • Biomarkers
  • Blood Glucose